Invitation to market dialogue: Compact bench model analysis platform for biomarkers in blood and faeces to UNN

b IgG, Adalimumab, Adalimumab IgG and UstekinumabSe attached invitations for further description.

The contracting authority needs an analysis platform for detection and measurement of specific biomarkers. The solution shall as a minimum cover the following analyses: Feces: H. pylori antigenBlod: Infliximab, Inflixima